Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Biocar Biotechnology is a high-tech enterprise based in Guangzhou, China, specializing in the research, development, and sales of pharmaceutical intermediates, APIs, and fine chemicals. Formerly known as Guangdong Yangye Pharmaceutical Factory and affiliated with the Wuhan Biocar Group, the company operates a large-scale production base focused on custom synthesis and the manufacturing of chemical raw materials. Its product portfolio includes a wide range of substances such as feed additives, veterinary drug intermediates, flavors, and fragrances. The company serves global markets, providing high-quality chemical products for research institutes, petrochemical enterprises, and medical material manufacturers. With a focus on 'Internet +' business acceleration, it maintains a strong presence in the chemical supply chain through its production facilities and international trade operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Biocar Biotechnology.